在接受内血管治疗的急性缺血性中风患者中基于血液的脆弱性指数
Marcus Rust1, Charlotte Küppers1, Omid Nikoubashman2
1Department of Neurology, University Hospital, RWTH Aachen University, Aachen, Germany.
Cerebrovascular diseases (Basel, Switzerland)
|July 28, 2024
概括
一个新的基于血液的脆弱性指数 (FI-B) 有效地识别了接受内血管治疗 (EVT) 的急性缺血性中风 (AIS) 患者的脆弱性. 较高的FI-B分数预测了增加的住院和3个月死亡率,以及更大的功能残疾.
科学领域:
- 老年学是一门学科.
- 神经学 神经学
- 生物化学 生物化学
背景情况:
- 脆弱性是生理脆弱性的关键指标,也是不利结果的预测因素.
- 医院脆弱性风险评分 (HFRS) 等现有的脆弱性指标是有价值的,但可以通过其他评估来补充.
- 接受内血管治疗 (EVT) 的急性缺血性中风 (AIS) 患者是脆弱人群,在此情况下,脆弱性评估至关重要.
研究的目的:
- 使用常规血液参数开发和验证基于血液的脆弱指数 (FI-B).
- 评估FI-B在接受EVT的AIS患者的住院死亡率,3个月死亡率和功能结果的预测能力.
- 检查新FI-B与已建立的HFRS之间的相关性.
主要方法:
- 对489名连续接受EVT的AIS患者的回顾性分析.
- 使用从入院值中选择的9个血液参数计算FI-B.
- 多变量回归模型用于确定FI-B与死亡率和功能结果的关联,并根据相关的共变量进行调整.
主要成果:
- FI-B与HFRS的阳性相关性较弱 (rho = 0.113,p = 0.016).
- 较高的FI-B三位数与年龄较大,中风前的功能依赖和并发症有关.
- 增加的FI-B独立地与更高的住院死亡率 (aOR = 1.29),3个月死亡率 (aOR = 1.26) 和更差的3个月功能结果 (aOR = 0.84) 相关.
结论:
- 基于血液的脆弱性指数 (FI-B) 是一种可行的工具,用于识别接受EVT的AIS患者的脆弱性.
- FI-B作为中风后短期和中期结果的独立预测器.
- 这种新的生物标志物为AIS患者的风险分层和个性化治疗策略提供了有希望的方法.
相关概念视频
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...